Quarterly report · Q1
7446.TEDINET S100Q8CO
Period2022-10-01 → 2022-12-31
Filed2023-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥9.4bn | 2022-10-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥37.3bn | 2021-10-01 → 2022-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥9.0bn | 2021-10-01 → 2021-12-31 | Cons. | Net sales |
| Operating income | ¥254m | 2022-10-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | ¥214m | 2021-10-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | ¥271m | 2022-10-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.0bn | 2021-10-01 → 2022-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥229m | 2021-10-01 → 2021-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥271m | 2022-10-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥229m | 2021-10-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥182m | 2022-10-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥658m | 2021-10-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥148m | 2021-10-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥187m | 2022-10-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | ¥155m | 2021-10-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥19.2bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥17.5bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥18.1bn | at 2021-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥12.5bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥10.8bn | at 2022-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥6.7bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥6.7bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥6.3bn | at 2021-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.4bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.4bn | at 2022-09-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥202.31 | 2022-10-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥728.76 | 2021-10-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥163.69 | 2021-10-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 34.7% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.7% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.6% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2022-10-01 → 2022-12-31 | ¥17m |
| Otherother segments | revenue external | 2022-10-01 → 2022-12-31 | ¥17m |
| jpcrp040300-q1r_E02810-000Foodreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥866m |
| jpcrp040300-q1r_E02810-000Foodreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥866m |
| jpcrp040300-q1r_E02810-000Pharmaceutical Productsreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥4.6bn |
| jpcrp040300-q1r_E02810-000Pharmaceutical Productsreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥4.6bn |
| jpcrp040300-q1r_E02810-000Reagent For Clinical Testreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥4.0bn |
| jpcrp040300-q1r_E02810-000Reagent For Clinical Testreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥4.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-10-01 → 2022-12-31 | ¥9.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-10-01 → 2022-12-31 | ¥9.4bn |
| Otherother segments | revenue | 2021-10-01 → 2021-12-31 | ¥20m |
| Otherother segments | revenue external | 2021-10-01 → 2021-12-31 | ¥20m |
| jpcrp040300-q1r_E02810-000Foodreportable segment | revenue | 2021-10-01 → 2021-12-31 | ¥823m |
| jpcrp040300-q1r_E02810-000Foodreportable segment | revenue external | 2021-10-01 → 2021-12-31 | ¥823m |
| jpcrp040300-q1r_E02810-000Pharmaceutical Productsreportable segment | revenue | 2021-10-01 → 2021-12-31 | ¥4.4bn |
| jpcrp040300-q1r_E02810-000Pharmaceutical Productsreportable segment | revenue external | 2021-10-01 → 2021-12-31 | ¥4.4bn |
| jpcrp040300-q1r_E02810-000Reagent For Clinical Testreportable segment | revenue | 2021-10-01 → 2021-12-31 | ¥3.8bn |
| jpcrp040300-q1r_E02810-000Reagent For Clinical Testreportable segment | revenue external | 2021-10-01 → 2021-12-31 | ¥3.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-10-01 → 2021-12-31 | ¥9.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-10-01 → 2021-12-31 | ¥9.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 369
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)太陽有限責任監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)中 村 憲 一 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)島 川 行 正 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 9042324000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 9409299000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 37333902000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 228777000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 271409000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 1003410000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 148370000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 182284000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 657620000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 153781000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 155279000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 492613000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 6342596000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 6733108000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 6681448000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 18135737000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 19188477000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 17519610000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 163.69 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 202.31 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 728.76 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.346 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.347 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.377 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 960000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 960000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 960000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 960000 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 58900 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 8999 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 899900 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 1200 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 960000 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 8999 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 58900 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 58900 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.061 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |